JORDAN MAHAN: Open Payments
NPI 1215225057 · GREENVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,064 in 58 payments from 18 companies in 2025. Trend: 2023 $882 · 2024 $606 · 2025 $1,064
Food & beverage: $1,064
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $260 |
| ABBVIE INC. | 10 | $161 |
| Novo Nordisk Inc | 5 | $108 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| Amgen Inc. | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| Abbott Laboratories | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
| Currax Pharmaceuticals LLC | 2 | $31 |
Products named: AIRSUPRA, BREZTRI, REXULTI, VRAYLAR, FARXIGA, Ozempic, QULIPTA, EVENITY.
Industry payments across TX — which companies pay providers there.
